Presentation is loading. Please wait.

Presentation is loading. Please wait.

How I treat disseminated intravascular coagulation

Similar presentations


Presentation on theme: "How I treat disseminated intravascular coagulation"— Presentation transcript:

1 How I treat disseminated intravascular coagulation
by Marcel Levi, and Marie Scully Blood Volume 131(8): February 22, 2018 ©2018 by American Society of Hematology

2 Mononuclear cells express tissue factor resulting in thrombin generation and subsequent fibrinogen to fibrin conversion, which, in combination with increased platelet vessel wall interaction and activation of platelets, contribute to microvascular clot form... Mononuclear cells express tissue factor resulting in thrombin generation and subsequent fibrinogen to fibrin conversion, which, in combination with increased platelet vessel wall interaction and activation of platelets, contribute to microvascular clot formation. P-selectin released from activated platelets further upregulates tissue factor expression. Binding of fibrin to Toll-like receptor 4 and activated coagulation proteases to specific protease activated receptors (PARs) on inflammatory cells (dotted lines) modulates inflammation through the additional release of proinflammatory cytokines. Cytokines also play a key role in the suppression of endogenous fibrinolysis and impairment of physiological anticoagulant pathways, such as the APC pathway. Marcel Levi, and Marie Scully Blood 2018;131: ©2018 by American Society of Hematology

3 Flowchart for the diagnostic and therapeutic management of DIC
Flowchart for the diagnostic and therapeutic management of DIC. LMW, low molecular weight. Flowchart for the diagnostic and therapeutic management of DIC. LMW, low molecular weight. Marcel Levi, and Marie Scully Blood 2018;131: ©2018 by American Society of Hematology


Download ppt "How I treat disseminated intravascular coagulation"

Similar presentations


Ads by Google